Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women
Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women
复制标题
DOI:
10.1016/j.radonc.2007.10.003
复制
发表时间:
2007-12-01
影响因子:
5.7
通讯作者:
Fourquet, Alain
中科院分区:
文献类型:
--
作者:
Bollet, Marc A.;Kirova, Youlia M.;Fourquet, Alain
Introduction: This study aimed to evaluate responses and outcome of hormone-therapy (HT) and radiotherapy (RT) given concurrently for large breast cancers in post-menopausal women.Material and methods: Forty-two breast carcinomas in 41 women were treated with HIT and concurrent RT to the breast lymph node bearing areas. For 30 tumours this was followed by breast surgery (with axillary lymph node dissection when the axilla had not been irradiated). RT delivered a median dose to the tumour of 50 Gy (48-66) and 75 Gy (65-84) for, respectively, preoperative and exclusive RT-HT. Median follow-up was 64 months.Results: Out of 42 clinically assessable tumours (after a mean dose of 50 Gy), 9 tumours (21%) had complete clinical responses, 24 (57%) partial responses, 9 (21%) stable disease. Breast-conserving surgery or exclusive RT-HT was possible in 74% of tumours. For 29 patients who underwent breast surgery, the rate of pathological complete responses was 17%. At 50 Gy no skin toxicity higher than grade 2 occurred. Five year OS, RFS and local control were, respectively, 85%, 84% and 97%. Lymphoedema occurred in one patient.Conclusion: Concurrent association of RT-HT demonstrated good efficacy, both in terms of clinical and pathological complete responses. It allowed breast conservation with acceptable tolerance and good 5-year local control. (c) 2007 Elsevier Ireland Ltd. All rights reserved.